Cyclophosphamide

ATC CODE

  • L01AA01

INDICATIONS AND NEMLC RECOMMENDATIONS

INDICATION AND NEMLC RECOMMENDATION 1

INDICATION

  • Adjuvant breast cancer.

NEMLC RECOMMENDATION

  • Approved
    (Cyclophosphamide plus Doxorubicin (AC)).

REVIEW INDICATORS

  • n/a

DATE RATIFIED

  • 27 November 2008


INDICATION AND NEMLC RECOMMENDATION 2

INDICATION

  • Adjuvant breast cancer.

NEMLC RECOMMENDATION

  • Approved
    (Cyclophosphamide plus methotrexate plus fluoro-uracil (CMF)).

REVIEW INDICATORS

  • n/a

DATE RATIFIED

  • 27 November 2008


INDICATION AND NEMLC RECOMMENDATION 3

INDICATION

  • Adjuvant breast cancer.

NEMLC RECOMMENDATION

  • Approved
    (Fluoro-uracil plus Doxorubicin plus cyclophosphamide (FAC)).

REVIEW INDICATORS

  • n/a

DATE RATIFIED

  • 27 November 2008